COMPANY PROFILE

Hari Mari

Explore full profile

Hari Mari Hari Mari gives $3 for every pair purchased to help fight pediatric cancer

Dallas, United StatesFounded 2012Health

Valuation $50–100M Last recorded · 2024

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Hari Mari

Hari Mari is a footwear company specializing in adventure-ready shoes for men, women, and children. The company operates in the retail market, focusing on high-quality flip flops, sandals, boots, and runners. Hari Mari's business model revolves around direct-to-consumer sales through its website and select retail partners. Revenue is generated from the sale of premium footwear, with a unique commitment to social responsibility by donating 1% of sales to support pediatric cancer research through their 'Flops Fighting Cancer' initiative. The company targets outdoor enthusiasts and families looking for durable and stylish footwear options.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2012
Headquarters: Dallas, United States
Employees: 65
Open positions: 3
Dealroom signal: 68.8/100
Industry: Health, Fashion
Sector: Health, Oncology, Hard Tech
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VC✓Equity / VC	Mar 2024	$10M	$40M	Landon Smith	↗
EARLY VCEquity / VC	Feb 2021	$1.8M	$7.2M	Undisclosed	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Hari Mari website traffic

Latest recorded traffic for Hari Mari is 28K monthly website visits, down 26.3% over the last three months. Hari Mari's team grew 3.2% over the past year.

Latest monthly visits28K 3-month web change-26.3% 1-year team growth+3.2%

Monthly website visitsApr 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Social Media & Influencer SpecialistDallas, TX · Marketing & Communication · Jul 29, 2026 Creative & Content Growth SpecialistDallas, TX · Marketing & Communication · Jul 29, 2026 West Coast Territory Account ManagerDallas, TX · Accounting · Jun 20, 2026

3 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
DPDISCO PharmaceuticalsBiotechnological research as well as the development, production and distribution of biotechnological products and solutions of all kinds	Cologne, Germany	Operational	37	$62M	$158M
ALAlulaDevelops a digital platform designed for cancer patients and caregivers	United States	Low Activity
THTHERAPANACEADevotion to Innovation, Compassion for Patients, Artificial Intelligence for Cancer Care	Paris, France	Operational
HEHelixNanoUses artificial intelligence to help cure genetic diseases	Cambridge, United States	Operational
CSCarevive SystemsProviding personalized and dynamic cancer care plans for patients	North Miami Beach, United States	Acquired
ANAnnoroadA leading developer and marketer on genomic innovation technologies for research and clinical market	Dongcheng District, China	Operational
COCelyad OncologyIntellectual property licensing for CAR T-cell therapies	Mont-Saint-Guibert, Belgium	Operational
BIBioNTechDevelops personalized immunotherapies with a focus on cancer medicine	Mainz, Germany	Operational